Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2023-04-26 Capital/Financing Update
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises ....
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to the stock exchange (BSE Limited) regarding the execution of a sale deed for a portion of the company's assets (premises in Thane One Building). It references prior member approval and provides detailed information about the transaction, including parties involved, terms, and confirmation that it is not a related party transaction. The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, which governs disclosures of material events by listed companies. The content is an announcement of a significant transaction (sale of company asset) rather than a financial report, management discussion, or other report types. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under Capital/Financing Update (CAP), which includes updates on company fundraising, financing activities, or capital structure changes, and also covers significant asset sales or disposals that impact the company's capital structure or asset base.
2023-04-26 English
Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated April 14, 2023 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the period April 1, ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended March 31, 2023. It certifies the handling of share certificates related to transmission, transposition, deletion of name, and issue of duplicate shares during the specified period. The document is a certificate from a company secretary firm, not a full financial report or announcement of financial results. It does not contain financial statements or management discussion but is a regulatory compliance certificate related to share transfer processes. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance certificate filing under SEBI regulations and does not match other more specific categories like Annual Report, Interim Report, or Director's Dealing.
2023-04-21 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to the stock exchange (BSE Limited) under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the loss of share certificates by a shareholder. The content is an intimation or notification related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data or analysis but is a regulatory disclosure about share certificate loss. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-04-21 English
Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended March 31, 2023, we hereby certify that on receipt of securities ....
Regulatory Filings
2023-04-20 English
As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical ....
Regulatory Filings Classification · 95% confidence The document is a compliance certificate addressed to the stock exchange (BSE Limited) regarding Regulation 7(3) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It confirms that share transfer activities were maintained during the fiscal year April 1, 2022 to March 31, 2023. The document is short (1841 characters) and is a formal attestation or certification rather than a financial report or detailed disclosure. It does not contain financial statements, management discussion, or detailed report content. Therefore, it fits the criteria of a Regulatory Filing (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2023-04-17 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about ....
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificates by a shareholder. It is addressed to the stock exchange and provides details of the lost certificates. The document is short (1423 characters) and serves as a regulatory notification rather than a financial report or detailed filing. It does not contain financial data, management discussion, or audit information. It is not an announcement of voting results, board changes, or capital changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-11 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.